Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Zydus Lifesciences Ltd spurts 1.81%, up for five straight sessions
Zydus Lifesciences Ltd is quoting at Rs 1105.45, up 1.81% on the day as on 12:44 IST on the NSE. The stock is up 18.87% in last one year as compared to a 3.64% fall in NIFTY and a 15.5% fall in the Nifty Pharma.
Medtech exporter Poly Medicure bets on high-tech pivot and acquisitions to fend off macro headwinds
The medtech major expects its growth rate to more than double in FY27 as it pivots from low-cost consumables to high-value equipment to counter Chinese competition and rising input costs.
Mankind Pharma Ltd eases for fifth straight session
Mankind Pharma Ltd is quoting at Rs 2412.2, down 0.47% on the day as on 13:19 IST on the NSE. The stock tumbled 2.88% in last one year as compared to a 3.49% slide in NIFTY and a 15.46% spurt in the Nifty Pharma index.
Laurus Labs Ltd spurts 1.14%, up for third straight session
Laurus Labs Ltd is quoting at Rs 1389.5, up 1.14% on the day as on 12:49 IST on the NSE. The stock is up 127.6% in last one year as compared to a 3.32% fall in NIFTY and a 15.48% fall in the Nifty Pharma index.
Wockhardt Ltd rises for third consecutive session
Wockhardt Ltd is quoting at Rs 1739.5, up 2.31% on the day as on 12:49 IST on the NSE. The stock is up 30.09% in last one year as compared to a 3.32% spurt in NIFTY and a 15.48% spurt in the Nifty Pharma index.
Himalaya Wealth launches ₹500 crore SME fund to back manufacturing, deeptech firms
The Category I AIF will target profitable growth-stage SMEs in sectors including aerospace, defence, industrial automation and healthcare, amid rising investor interest in manufacturing-led businesses.
Trade Setup for May 27: Nifty holds on to key levels as market moves from one expiry to another
The Nifty Bank was the key contributor in the Nifty exhibiting sluggish moves on expiry day, but unlike the Nifty, the banking index continued to trade in a broad range. Despite a 500-point fall from the day's high, the index managed to hold on to the 55,000 mark on a closing basis, something the bulls could take heart from. Tuesday's high of 55,536 will be the first level to watch on the upside.
J B Chemicals & Pharmaceuticals Ltd rises for third consecutive session
J B Chemicals & Pharmaceuticals Ltd is quoting at Rs 2243.5, up 2.32% on the day as on 12:49 IST on the NSE. The stock is up 31.82% in last one year as compared to a 4.24% spurt in NIFTY and a 14.46% spurt in the Nifty Pharma index.
Torrent Pharmaceuticals Ltd spurts 3.06%, rises for third straight session
Torrent Pharmaceuticals Ltd is quoting at Rs 4623.4, up 3.06% on the day as on 12:49 IST on the NSE. The stock is up 45.05% in last one year as compared to a 4.24% fall in NIFTY and a 14.46% fall in the Nifty Pharma index.
Aurobindo Pharma Ltd up for third consecutive session
Aurobindo Pharma Ltd is quoting at Rs 1541.4, up 1.57% on the day as on 12:49 IST on the NSE. The stock is up 29.73% in last one year as compared to a 3.98% slide in NIFTY and a 15.38% slide in the Nifty Pharma index.
Market Trading Guide: Tata Tech, Nazara Tech among 5 stock recommendations for Wednesday for gains up to 22%
Market sentiment leans bearish short-term (Nifty resistance 23,800). Experts recommend buying five stocks: Angel One, Tata Technologies, Garware Hi Tech Films, Granules India, and Nazara Technologies, citing bullish technical indicators and strong upside potential.
Nifty could hit 27,000 once geopolitical tensions ease: Bajaj Finserv AMC CIO
Bajaj Finserv AMC CIO Nimesh Chandan projects 15% earnings growth for Nifty in FY28, with EPS rising to the ₹1,420–1,440 range, making valuations look attractive. He backs metals, construction, and cement as long-term plays on a global supply chain shift, holds gold and silver in the multi-asset portfolio, and flags El Niño and elevated US yields as key risks keeping Indian interest rates high in the near term.